Isolated limb perfusion for soft-tissue sarcoma and regional melanoma.
Olfa Derbel(Hôpital Edouard Herriot), Jean‐Yves Blay(Université Claude Bernard Lyon 1), A. Stoltz(Centre Léon Bérard), Arnaud de la Fouchardière(Université Claude Bernard Lyon 1), P. Combemale(Centre Léon Bérard), Isabelle Ray‐Coquard(Centre Léon Bérard), Pierre Méeus(Centre Léon Bérard), Aurélien Dupré(Centre Hospitalier Universitaire de Clermont-Ferrand), Dominique Ranchère‐Vince(Centre Léon Bérard), Eve‐Marie Neidhardt(Centre Léon Bérard), Philippe A. Cassier(Centre Léon Bérard)
Cited by 0
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k